首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

British Journal Of Clinical Pharmacology

British Journal Of Clinical Pharmacology杂志,由Wiley-Blackwell Publishing Ltd出版,于1974年创刊,Monthly,出版语言English,ISSN:0306-5251,E-ISSN:1365-2125。

投稿咨询
British Journal Of Clinical Pharmacology
British Journal Of Clinical Pharmacology
British Journal Of Clinical Pharmacology
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3
CiteScore
7.3
期刊收录
SCI、SCIE

British Journal Of Clinical Pharmacology(中文译名:《英国临床药理学杂志》),ISSN:0306-5251,EISSN:1365-2125,是Wiley-Blackwell Publishing Ltd出版的国际性学术期刊,创刊于1974年,以Monthly形式稳定发行,2026年总发文量约358篇。该刊采用非OA开放访问,学科归属为医学 - 药学。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3,2025年期刊CiteScore为7.3,2025年期刊自引率约6.7%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。British Journal Of Clinical Pharmacology长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期约1月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,EnglandUSA、Netherlands、France、Australia、GERMANY (FED REP GER)、CHINA MAINLAND等为核心发文国家与地区;UNIVERSITY OF LONDONINSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)、LEIDEN UNIVERSITY、UTRECHT UNIVERSITY、ASSISTANCE PUBLIQUE HOPITAUX PARIS (APHP)、ERASMUS UNIVERSITY ROTTERDAM、UNIVERSITY OF SYDNEY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
2区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 169 / 356

52.7

学科:PHARMACOLOGY & PHARMACY SCIE Q2 146 / 356

59.13

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 138 / 352

60.9

学科:PHARMACOLOGY & PHARMACY SCIE Q2 122 / 353

65.58


中国学者近期发文

1
Comment on revisiting the association between anticholinergic burden and frailty in people with HI

Author:Wang, Yu

Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/bcp.70555

2
Integrating generative AI and genetic causal inference identifies metformin as a repurposing candidate for normal tension glaucom

Author:Jiang, Junhong; Hu, Di; Zhang, Qi; Lin, Zenan

Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/bcp.70537

3
Evaluating the clinical efficacy of combinatorial pharmacogenomic-guided treatment in schizophrenia patient

Author:Li, Jiqing; Xia, Weili; Fu, Ping; Yu, Tiangui; Xue, Fuzhong

Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/bcp.70568

4
Placebo response and its influencing factors in acne vulgaris: A model-based meta-analysi

Author:Luo, Jieren; Yu, Jiesen; Cai, Zihao; Zhu, Haoxiang; Liu, Tingze; Zheng, Qingshan; He, Xiang; Li, Lujin

Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/bcp.70468

5
The evolving therapeutic landscape of spinal muscular atrophy - A scoping review of investigational agents, emerging delivery technologies and strategic innovation

Author:Belancic, Andrej; Eustaquio, Patrick; Gkrinia, Elvira Meni Maria; Stevic, Ivana; Javor, Eugen; Lam, Yun Wah; Jankovic, Slobodan; Vitezic, Dinko

Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/bcp.70502

6
Application of paediatric cetirizine PBPK model to guide precision medicine and understand renal P-glycoprotein ontogen

Author:Li, Yafen; Yao, Xueting; Liu, Wei; Lei, Zihan; Xu, Yue; Li, Haiyan; Zhou, Wei; Liu, Dongyang

Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/bcp.70517

7
Response to: Comment on 'comparative effectiveness of clopidogrel vs. potent P2Y12 inhibitors in CYP2C19 normal metabolizers following percutaneous coronary intervention: A real-world cohort study

Author:Hsu, Hsing-Yu; Chang, Shih-Sheng; Chen, Ke-Wei; Chang, Kuan-Cheng; Tsai, Fuu-Jen

Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/bcp.70528

8
Tolerability and pharmacokinetics of leritrelvir in Chinese participants with severe renal impairment and healthy matched control subject

Author:Zhou, Zi-yi; Wen, Xiao-qing; Zhang, Wen-rui; Huang, Yue-yuan; Li, Hai-jun; Li, You-yun; Huang, Ji-yi; Luo, Xi

Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/bcp.70474

9
Impact of antibiotics allergy labels on clinical outcomes in ICU patients: A 15-year retrospective cohort stud

Author:Su, Jiachun; Yuan, Lili; Li, Ying

Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/bcp.70444

10
SHR-1703, a novel long-acting anti-interleukin-5 monoclonal antibody, in asthma patients: A randomized, double-blind, placebo-controlled phase 1 stud

Author:Yang, Ling; He, Lixiu; Zhang, Yajun; Fu, Meng; Li, Xiaotong; Luo, Zhu

Journal: BRITISH JOURNAL OF CLINICAL PHARMACOLOGY. 2026; Vol. , Issue , pp. -. DOI: 10.1002/bcp.70439


在线咨询

British Journal Of Clinical Pharmacology

国际简称:BRIT J CLIN PHARMACO参考译名:英国临床药理学杂志

年发文量:358 CiteScore:7.3 是否预警:否 Gold OA文章占比:48.21% 研究类文章占比:82.40%

杂志社联系方式:WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148

British Journal Of Clinical Pharmacology